GENTLE-PACE——一项多中心、随机、双盲研究，比较心脏神经消融术与永久性起搏治疗有症状心动过缓且植入起搏器患者的疗效和安全性。 - Suppr

GENTLE-PACE - A multicenter, randomized, double-blinded research study comparinG the Efficacy and safety of cardioNeuroablaTion vs. permanent pacing in patients with an implantabLE PACEmaker for symptomatic bradycardia.

作者信息

Skoczyński Przemysław, Hrymniak Bruno, Skonieczny Bartosz, Biel Bartosz, Josiak Krystian, Krakowiak Bartosz, Ptaszkowski Kuba, Gołba Krzysztof S, Bednarek Jacek, Kosior Jarosław, Stodółkiewicz-Nowarska Edyta, Skotny Anna, Aktanorowicz Patrycja, Andrejków Agnieszka, Ratajska Anna, Zając Magdalena, Banasiak Waldemar, Doroszko Adrian, Zyśko Dorota, Stec Sebastian, Pachón-Mateos José Carlos, Jagielski Dariusz

机构信息

Department of Cardiology, Center for Heart Diseases, 4th Military Hospital, Wroclaw, Poland.

Department of Emergency Medicine, Wroclaw Medical University, Wroclaw, Poland.

出版信息

Cardiol J. 2024;31(6):909-916. doi: 10.5603/cj.100718. Epub 2024 Nov 25.

DOI:10.5603/cj.100718

PMID:39584414

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11706266/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b0a/11706266/ca40ce8a34a5/cardj-31-6-909f1.jpg

相似文献

GENTLE-PACE - A multicenter, randomized, double-blinded research study comparinG the Efficacy and safety of cardioNeuroablaTion vs. permanent pacing in patients with an implantabLE PACEmaker for symptomatic bradycardia.GENTLE-PACE——一项多中心、随机、双盲研究，比较心脏神经消融术与永久性起搏治疗有症状心动过缓且植入起搏器患者的疗效和安全性。

Cardiol J. 2024;31(6):909-916. doi: 10.5603/cj.100718. Epub 2024 Nov 25.

Safety and efficiency of ventricular pacing prevention with an AAI-DDD changeover mode in patients with sinus node disease or atrioventricular block: impact on battery longevity-a sub-study of the ANSWER trial.采用AAI-DDD转换模式预防窦房结疾病或房室传导阻滞患者心室起搏的安全性和有效性：对电池寿命的影响——ANSWER试验的一项子研究

Europace. 2016 May;18(5):739-46. doi: 10.1093/europace/euv358. Epub 2015 Nov 26.

Cardioneuroablation for pediatric patients with functional sinus node dysfunction and paroxysmal atrioventricular block.心脏神经消融术治疗功能性窦房结功能障碍和阵发性房室传导阻滞的儿科患者。

J Cardiovasc Electrophysiol. 2024 Feb;35(2):221-229. doi: 10.1111/jce.16145. Epub 2023 Dec 1.

Incidence and predictors of pacemaker implantation at follow-up after reversible high-degree sinus node dysfunction or atrioventricular block.在可恢复的高度窦房结功能障碍或房室传导阻滞随访时，起搏器植入的发生率和预测因素。

Pacing Clin Electrophysiol. 2023 Aug;46(8):994-1002. doi: 10.1111/pace.14755. Epub 2023 Jun 15.

Treatment of Symptomatic Functional Atrioventricular Block by Cardioneuroablation as an Alternative to Pacemaker Implantation.心脏神经消融术治疗有症状的功能性房室传导阻滞作为起搏器植入的替代方法

JACC Case Rep. 2022 Aug 3;4(15):990-995. doi: 10.1016/j.jaccas.2022.04.029.

Shared Decision Making and Cardioneuroablation Allow Discontinuation of Permanent Pacing in Patients with Vagally Mediated Bradycardia.共同决策与心脏神经消融术可使迷走神经介导的心动过缓患者停用永久性起搏器

J Cardiovasc Dev Dis. 2023 Sep 11;10(9):392. doi: 10.3390/jcdd10090392.

Effect of age on clinical impact and mid-term denervation in patients undergoing cardioneuroablation.年龄对心神经消融术患者临床影响和中期去神经化的影响。

Sci Rep. 2024 Nov 11;14(1):27546. doi: 10.1038/s41598-024-78665-z.

A case report of cardiac neuromodulation in a young patient with a third-degree atrioventricular block.一名年轻三度房室传导阻滞患者心脏神经调节的病例报告。

Front Cardiovasc Med. 2024 Apr 3;11:1370522. doi: 10.3389/fcvm.2024.1370522. eCollection 2024.

Cardioneuroablation for the Treatment of Hypervagotonic Sinus Node Dysfunction.心脏神经消融术治疗高迷走神经张力性窦房结功能障碍

JACC Case Rep. 2024 Jan 9;29(4):102185. doi: 10.1016/j.jaccas.2023.102185. eCollection 2024 Feb 21.

Reduction of unnecessary right ventricular pacing by managed ventricular pacing and search AV+ algorithms in pacemaker patients: 12-month follow-up results of a randomized study.起搏器患者中通过优化心室起搏和搜索AV+算法减少不必要的右心室起搏：一项随机研究的12个月随访结果

Europace. 2014 Nov;16(11):1595-602. doi: 10.1093/europace/euu055. Epub 2014 Apr 4.

引用本文的文献

Cardioneuroablation in the Management of Vagally Mediated Bradyarrhythmias-A Comprehensive Review of Ongoing Randomized Controlled Trials.心脏神经消融治疗迷走神经介导的缓慢性心律失常——正在进行的随机对照试验的综合综述

J Clin Med. 2025 Jan 17;14(2):592. doi: 10.3390/jcm14020592.

本文引用的文献

Reevaluation of indications for permanent pacemaker implantation after cardioneuroablation.心脏神经消融术后永久性起搏器植入适应证的重新评估

Kardiol Pol. 2023;81(12):1272-1275. doi: 10.33963/v.kp.97828. Epub 2023 Nov 24.

Discontinuation of cardiac implantable electronic device therapy after transvenous lead extraction.经静脉导线拔除后心脏植入式电子设备治疗的停药。

Kardiol Pol. 2023;81(11):1113-1121. doi: 10.33963/v.kp.97655. Epub 2023 Nov 8.

J Cardiovasc Dev Dis. 2023 Sep 11;10(9):392. doi: 10.3390/jcdd10090392.

Clinical controversy: methodology and indications of cardioneuroablation for reflex syncope.临床争议：反射性晕厥的心神经消融术的方法和适应症

Europace. 2023 May 19;25(5). doi: 10.1093/europace/euad033.

Rationale and design of SAN.OK randomized clinical trial and registry: Comparison of the effects of evidence-based pacemaker therapy and cardioneuroablation in sinus node dysfunction.SAN.OK随机临床试验与注册研究的原理与设计：基于证据的起搏器治疗与心脏神经消融术治疗窦房结功能障碍的效果比较

Cardiol J. 2022;29(6):1031-1036. doi: 10.5603/CJ.a2022.0103. Epub 2022 Nov 17.

Cardioneuroablation for Reflex Syncope: Efficacy and Effects on Autonomic Cardiac Regulation-A Prospective Randomized Trial.心脏神经消融术治疗反射性晕厥：疗效及对自主心脏调节的影响——一项前瞻性随机试验

JACC Clin Electrophysiol. 2023 Jan;9(1):85-95. doi: 10.1016/j.jacep.2022.08.011. Epub 2022 Aug 28.

Long-Term Implications of Pacemaker Insertion in Younger Adults: A Single Centre Experience.起搏器植入对年轻成年人的长期影响：单中心经验。

Heart Lung Circ. 2022 Jul;31(7):993-998. doi: 10.1016/j.hlc.2022.01.009. Epub 2022 Feb 24.

2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.2021年欧洲心脏病学会心脏起搏与心脏再同步治疗指南。

Eur Heart J. 2021 Sep 14;42(35):3427-3520. doi: 10.1093/eurheartj/ehab364.

Unifocal Right-Sided Ablation Treatment for Neurally Mediated Syncope and Functional Sinus Node Dysfunction Under Computed Tomographic Guidance.在 CT 引导下对神经介导性晕厥和功能性窦房结功能障碍进行单侧右侧消融治疗。

Circ Arrhythm Electrophysiol. 2018 Sep;11(9):e006604. doi: 10.1161/CIRCEP.118.006604.

Complications of pulmonary vein isolation in atrial fibrillation: predictors and comparison between four different ablation techniques: Results from the MIddelheim PVI-registry.心房颤动肺静脉隔离的并发症：四种不同消融技术的预测因素和比较：来自 MIddelheim PVI 注册研究的结果。

Europace. 2018 Aug 1;20(8):1279-1286. doi: 10.1093/europace/eux233.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

GENTLE-PACE - A multicenter, randomized, double-blinded research study comparinG the Efficacy and safety of cardioNeuroablaTion vs. permanent pacing in patients with an implantabLE PACEmaker for symptomatic bradycardia.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献